Skip to main content


Latest articles

08-12-2021 | Oncology | News | Article

Appropriate framework must guide targeted therapy for metastatic breast cancer

Multigene sequencing identifies patients with metastatic breast cancer who will benefit from targeted therapy, but its use must be driven by a framework of actionability, show data presented at the 2021 San Antonio Breast Cancer Symposium.

08-12-2021 | Oncology | News | Article

​​​​​​​No benefit of adjuvant metformin in HR-positive, negative early breast cancer

Adjuvant treatment with metformin does not improve the outcomes of patients with HR-positive or negative early breast cancer, suggest trial data presented at the 2021 San Antonio Breast Cancer Symposium.

07-12-2021 | Oncology | News | Article

ESMO issues recommendations for managing bladder cancer

Read about this Clinical Practice Guideline here

06-12-2021 | Oncology | News | Article

Vibostolimab ‘promising’ for advanced solid tumors

Vibostolimab given alone or in combination with pembrolizumab is well tolerated and demonstrates antitumor activity in patients with advanced solid tumors, including non-small-cell lung cancer, show results of a first-in-human study of the antibody targeting the TIGIT domain. 

06-12-2021 | Oncology | News | Article

High prevalence of multifocal disease highlighted for paediatric papillary thyroid carcinoma

Research points to a high prevalence of multifocal disease in children with papillary thyroid carcinoma, with age and tumour stage possible risk factors for this diagnosis.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

03-12-2021 | Oncology | News | Article

ESMO malignant pleural mesothelioma guideline published

Click through for more information

Image Credits